$BBAI
BigBear.ai Holdings Inc Stock $bbai

$bbai Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000162828022029506 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$40.36M	$40.65M	$0.00
YoY Change	-72.28%
Cost Of Revenue	$28.57M	$28.90M	$29.42M
YoY Change	-74.38%	-1.77%
Gross Profit	$11.79M	$11.75M	$10.80M
YoY Change	-65.41%	8.83%
Gross Profit Margin	29.2%	28.91%
Selling, General & Admin	$15.57M	$20.23M	$1.964M
YoY Change	-84.8%	930.08%
% of Gross Profit	132.12%	172.18%	18.19%
Research & Development	$1.199M	$1.785M	$1.363M
YoY Change	-80.13%	30.96%
% of Gross Profit	10.17%	15.19%	12.62%
Depreciation & Amortization	$1.994M	$2.038M
YoY Change	-72.54%
% of Gross Profit	16.92%	17.34%
Operating Expenses	$16.77M	$22.02M	$1.964M
YoY Change	-84.54%	1020.95%
Operating Profit	-$4.984M	-$12.40M	-$1.964M
YoY Change	-93.3%	531.04%
Interest Expense	-$3.743M	$3.557M	$9.050K
YoY Change	-90.9%	39203.87%
% of Operating Profit
Other Income/Expense, Net	-$7.000K	-$8.000K	$32.99K
YoY Change	-103.55%	-124.25%
Pretax Income	-$30.12M	-$15.86M	-$1.922M
YoY Change	-74.52%	725.0%
Income Tax	-$226.0K	$252.0K	$2.699K
% Of Pretax Income
Net Earnings	-$29.90M	-$16.11M	-$1.925M
YoY Change	-74.94%	736.93%
Net Earnings / Revenue	-74.08%	-39.63%
Basic Earnings Per Share		-$0.13	-$0.03
Diluted Earnings Per Share	-$0.23	-$0.13	-$191.5K
COMMON SHARES
Basic Shares Outstanding	126.3M shares	126.3M shares	105.0M shares
Diluted Shares Outstanding		126.3M shares	105.0M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.63M	$21.96M	$982.3K
YoY Change	-81.67%	2135.17%
Cash & Equivalents	$12.63M	$21.96M	$982.2K
Short-Term Investments
Other Short-Term Assets	$10.30M	$5.084M	$347.7K
YoY Change	-90.47%	1362.31%
Inventory
Prepaid Expenses
Receivables	$31.40M	$31.65M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$54.34M	$60.01M	$1.331M
YoY Change	-73.65%	4408.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.071M	$1.528M
YoY Change	463.17%
Goodwill	$48.68M	$67.13M
YoY Change	-46.87%
Intangibles	$85.69M	$87.55M
YoY Change	2.44%
Long-Term Investments			$358.8M
YoY Change
Other Assets	$534.0K	$692.0K	$114.5K
YoY Change	-31.54%	504.42%
Total Long-Term Assets	$141.0M	$156.9M	$358.9M
YoY Change	-20.42%	-56.29%
TOTAL ASSETS
Total Short-Term Assets	$54.34M	$60.01M	$1.331M
Total Long-Term Assets	$141.0M	$156.9M	$358.9M
Total Assets	$195.3M	$216.9M	$360.3M
YoY Change	-49.05%	-39.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.42M	$7.426M	$26.47K
YoY Change	181.68%	27954.4%
Accrued Expenses	$14.17M	$17.49M	$2.312M
YoY Change	32.02%	656.64%
Deferred Revenue	$2.022M	$4.758M
YoY Change	-51.94%
Short-Term Debt	$0.00	$0.00	$57.39K
YoY Change		-100.0%
Long-Term Debt Due	$2.059M	$769.0K
YoY Change	-51.36%
Total Short-Term Liabilities	$35.76M	$32.74M	$2.402M
YoY Change	-48.93%	1262.95%
LONG-TERM LIABILITIES
Long-Term Debt	$192.3M	$191.8M	$0.00
YoY Change	1.03%
Other Long-Term Liabilities	$5.102M	$36.00K	$12.94M
YoY Change	1474.69%	-99.72%
Total Long-Term Liabilities	$197.4M	$191.9M	$12.94M
YoY Change	3.53%	1382.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.76M	$32.74M	$2.402M
Total Long-Term Liabilities	$197.4M	$191.9M	$12.94M
Total Liabilities	$233.2M	$225.0M	$15.34M
YoY Change	-10.64%	1366.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$253.1M	-$223.2M
YoY Change	92.61%
Common Stock	$272.5M	$272.4M
YoY Change	7.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$37.87M	-$8.099M	-$13.89M
YoY Change
Total Liabilities & Shareholders Equity	$195.3M	$216.9M	$360.3M
YoY Change	-49.05%	-39.79%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$29.90M	-$16.11M	-$1.925M
YoY Change	-74.94%	736.93%
Depreciation, Depletion And Amortization	$1.994M	$2.038M
YoY Change	-72.54%
Cash From Operating Activities	-$10.53M	-$6.394M	-$669.4K
YoY Change	-39.89%	855.21%
INVESTING ACTIVITIES
Capital Expenditures	$33.00K	-$228.0K
YoY Change	-105.12%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$89.00K	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$33.00K	-$317.0K	$0.00
YoY Change	-100.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.238M	-1.163M	0.000
YoY Change	-100.68%
NET CHANGE
Cash From Operating Activities	-10.53M	-6.394M	-669.4K
Cash From Investing Activities	-33.00K	-317.0K	0.000
Cash From Financing Activities	1.238M	-1.163M	0.000
Net Change In Cash	-9.323M	-7.874M	-669.4K
YoY Change	-105.85%	1076.31%
FREE CASH FLOW
Cash From Operating Activities	-$10.53M	-$6.394M	-$669.4K
Capital Expenditures	$33.00K	-$228.0K
Free Cash Flow	-$10.56M	-$6.166M
YoY Change	-37.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001836981
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40031
	dei	Entity Registrant Name EntityRegistrantName	BigBear.ai Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-4164597
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6811 Benjamin Franklin Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31652000	usd
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21046
	dei	City Area Code CityAreaCode	410
	dei	Local Phone Number LocalPhoneNumber	312-0885
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126275250	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21955000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	101021000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	98000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43000	usd
CY2021Q4	us-gaap	Assets Assets	383322000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7426000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28605000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1323000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5084000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	60014000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	206182000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1528000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1078000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	67125000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	91636000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	87551000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83646000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	692000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	780000	usd
CY2022Q3	us-gaap	Assets Assets	216910000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5475000	usd
CY2022Q3	us-gaap	Debt Current DebtCurrent	769000	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	4233000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17494000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4758000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	44827000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2290000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	541000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	32737000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70018000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	191830000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	406000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	248000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	36000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	324000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	225009000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	260954000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126273215	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126273215	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135566227	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	272406000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	253744000	usd
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9952803	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57350000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-223169000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-131390000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8099000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	216910000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383322000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40651000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40219000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	114654000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112100000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	28900000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	29421000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	83446000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	81859000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	11751000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	10798000	usd
	us-gaap	Gross Profit GrossProfit	31208000	usd
	us-gaap	Gross Profit GrossProfit	30241000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20233000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12038000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	69205000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32557000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1785000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1363000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7194000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4158000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	1562000	usd
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	1562000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	566000	usd
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2151000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12395000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2603000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-84156000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6474000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3557000	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1870000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	10666000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5579000	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	102000	usd
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1564000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-8000	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-12000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15858000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4473000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-93270000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12052000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	252000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1327000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1491000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3294000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-16110000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8758000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126270282	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128103625	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126270282	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128103625	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5789000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-16110000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2222000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8099000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	94841000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3146000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	91725000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91779000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11160000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	57350000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7501000	usd
	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8099000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	100397000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8758000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	91725000	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-91779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8758000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5764000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5432000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1570000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	429000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11160000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	86000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	55000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1450000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3341000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	-1564000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2359000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-163000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	297000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	288000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3549000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100896000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5829000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1946000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6737000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-993000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4733000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1004000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1595000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1760000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	263000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38390000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1222000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4465000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	224000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	736000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	601000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5201000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-825000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3464000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	825000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-104375000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	675000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-147966000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1072000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9704000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21955000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10776000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	7501000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21955000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	101021000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21955000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q4	bbai	Holding Period Of Shares HoldingPeriodOfShares	P3M
CY2021Q4	bbai	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	101958000	usd
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	17391304	shares
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	11.50
CY2021Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	114393000	usd
CY2021Q4	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	9802000	usd
CY2021Q4	bbai	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	501000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	bbai	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	75000000	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2021Q4	bbai	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	105000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8000000	shares
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q2	bbai	Goodwill Increase In Weighted Average Cost Of Capital Percentage GoodwillIncreaseInWeightedAverageCostOfCapitalPercentage	0.01
CY2022Q2	bbai	Goodwill Reduction In Forecasted Revenues Percentage GoodwillReductionInForecastedRevenuesPercentage	0.03
CY2021Q4	us-gaap	Goodwill Goodwill	91636000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	67125000	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4234000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2217000	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	850000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	4265000	usd
CY2022Q3	bbai	Pre Contract Costs PreContractCosts	0	usd
CY2021Q4	bbai	Pre Contract Costs PreContractCosts	546000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5084000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	200769000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	204233000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9011000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12446000	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	3567000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	842000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1481000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	882000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17494000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	194597000	usd
	bbai	Share Repurchase Program Release Of Escrow ShareRepurchaseProgramReleaseOfEscrow	100896000	usd
	bbai	Share Repurchase Program Reclassified To Cash And Cash Equivalent ShareRepurchaseProgramReclassifiedToCashAndCashEquivalent	125000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8170000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9636000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	192599000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	769000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4233000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	191830000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	200000000	usd
	bbai	Operating Leases Of Lessee Renewal Term OperatingLeasesOfLesseeRenewalTerm	P5Y
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	44827000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1281000	usd
	bbai	Derivative Liability Settlement DerivativeLiabilitySettlement	43546000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.016
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.297
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.016
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.273
CY2021Q4	bbai	Share Repurchase Obligation Liability ShareRepurchaseObligationLiability	9952803	shares
CY2022Q1	bbai	Period For Reduced Price Repurchase PeriodForReducedPriceRepurchase	P3M
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	10.125
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	101021000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126273215	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
	bbai	Common Stock Voting Rights Vote For Each Share CommonStockVotingRightsVoteForEachShare	1	vote
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.92
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	482000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.99
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	606933	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.92
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	231314	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.14
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	857619	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	19088	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.62
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2222000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11160000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16110000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16110000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3146000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3146000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-91779000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91779000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8758000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8758000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126270282	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126270282	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128103625	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128103625	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	857619	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.34
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	18844600	shares
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	1118720	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40651000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40219000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	114654000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112100000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40651000	usd
CY2022Q3	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40219000	usd
CY2021Q3	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	114654000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112100000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1323000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4758000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4207000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	113000000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.98
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40651000	usd
CY2022Q3	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	13756000	usd
CY2022Q3	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.34
CY2022Q3	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	1434000	usd
CY2022Q3	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	-571000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20233000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1785000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	1562000	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	566000	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12395000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-102000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	3557000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-8000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15858000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40219000	usd
CY2021Q3	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	14443000	usd
CY2021Q3	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.36
CY2021Q3	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	3645000	usd
CY2021Q3	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	0	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12038000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1363000	usd
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2603000	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	1870000	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4473000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	114654000	usd
	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	38477000	usd
	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.34
	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	4989000	usd
	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	-2280000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	69205000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7194000	usd
	us-gaap	Restructuring Charges RestructuringCharges	1562000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2151000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-84156000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1564000	usd
	us-gaap	Interest Expense InterestExpense	10666000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-12000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-93270000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112100000	usd
	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	38743000	usd
	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.35
	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	8502000	usd
	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32557000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4158000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6474000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Interest Expense InterestExpense	5579000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12052000	usd
CY2022Q3	us-gaap	Assets Assets	216910000	usd
CY2021Q4	us-gaap	Assets Assets	383322000	usd

Files In Submission

Name	View Source	Status
0001628280-22-029506-index-headers.html	Edgar Link	pending
0001628280-22-029506-index.html	Edgar Link	pending
0001628280-22-029506.txt	Edgar Link	pending
0001628280-22-029506-xbrl.zip	Edgar Link	pending
bbai-20220930.htm	Edgar Link	pending
bbai-20220930.xsd	Edgar Link	pending
exhibit102secondamendmentt.htm	Edgar Link	pending
exhibit311-ceocertificatio.htm	Edgar Link	pending
exhibit312-cfocertificatio.htm	Edgar Link	pending
exhibit321-906ceo9302022.htm	Edgar Link	pending
exhibit322-906cfo9302022.htm	Edgar Link	pending
bbai-20220930_cal.xml	Edgar Link	unprocessable
bbai-20220930_def.xml	Edgar Link	unprocessable
bbai-20220930_lab.xml	Edgar Link	unprocessable
bbai-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bbai-20220930_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBAI
BigBear.ai Holdings Inc Stock $bbai

2022 Q4 Form 10-Q Financial Statement

#000162828022029506 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI BigBear.ai Holdings Inc Stock $bbai

2022 Q4 Form 10-Q Financial Statement

#000162828022029506 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI
BigBear.ai Holdings Inc Stock $bbai